1. Kawano M, Iwasaki T, Itonaga I, Kubota Y, Tanaka K, Tsumura H. Analysis of the signal cross talk via CCL26 in the tumor microenvironment in osteosarcoma. Sci Rep, 11(1):18099. doi: 10.1038/s41598-021-97153-2. 2021.
2. Oda Y, Tanaka K, Hirose T, Hasegawa T, Hiruta N, Hisaoka M, Yoshimoto M, Otsuka H, Bekki H, Ishii T, Endo M, Kunisada T, Hiruma T, Tsuchiya H, Katagiri H, Matsumoto Y, Kawai A, Nakayama R, Kawashima H, Takenaka S, Emori M, Watanuki M, Yoshida Y, Okamoto T, Mizusawa J, Fukuda H, Ozaki T, Iwamoto Y, Noijma T. Standardization of evaluation method and prognostic significance of histological response to preoperative chemotherapy in high-grade non-round cell soft tissue sarcomas: a report from the central pathology review for the Japan Clinical Oncology Group study JCOG0304. BMC Cancer, 22(1):94. doi: 10.1186/s12885-022-09195-y. 2022.
3. Kawai A, Araki N, Ae K, Akiyama T, Ozaki T, Kawano H, Kunisada T, Sumi M, Takahashi S, Tanaka K, Tsukushi S, Naka N, Nishida Y, Miyachi M, Yamamoto N, Yoshida A, Yonemoto T, Yoshida M, Iwata S. Clinical practice guidelines for the diagnosis and treatment of soft tissue tumors 2020. J Orthop Sci, S0949-2658(22)00060-4. doi: 10.1016/j.jos.2021.11.023. 2022.
4. Tanaka K, Ozaki T. Management of the elderly patients with bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group. Jpn J Clin Oncol, hyac027. doi: 10.1093/jjco/hyac027. 2022.
5. Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, Rajasekhar VK, Yoshida A, Kondo H, Hata T, Tazawa H, Dogan Y, Moore MAS, Fujiwara T, Ozaki T, Purdue E, Healey JH. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment. Mol Cancer Ther. 2021 Aug;20(8):1388-1399. doi: 10.1158/1535-7163.MCT-20-0591.
6. Nakata E, Fujiwara T, Kunisada T, Ito T, Takihira S, Ozaki T.Immunotherapy for sarcomas.Jpn J Clin Oncol. 2021 Apr 1;51(4):523-537. doi:10.1093/jjco/hyab005.
7. Omori T, Tazawa H, Yamakawa Y, Osaki S, Hasei J, Sugiu K, Komatsubara T, Fujiwara T, Yoshida A, Kunisada T, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression.PLoS One. 2021 Apr 22;16(4):e0250643. doi: 10.1371/journal.pone.0250643. eCollection 2021.
8. Huang R, Fujimura A, Nakata E, Takihira S, Inoue H, Yoshikawa S, Hiyama T, Ozaki T, Kamiya A. Adrenergic signaling promotes the expansion of cancer stem-like cells of malignant peripheral nerve sheath tumors. Biochem Biophys Res Commun. 2021 Jun 11;557:199-205. doi: 10.1016/j.bbrc.2021.03.172.
9. Ise M, Nakata E, Katayama Y, Hamada M, Kunisada T, Fujiwara T, Nakahara R, Takihira S, Sato K, Akezaki Y, Senda M, Ozaki T. Prevalence of Psychological Distress and Its Risk Factors in Patients with Primary Bone and Soft Tissue Tumors. Healthcare (Basel). 2021 May 11;9(5):566. doi: 10.3390/healthcare9050566.
10. Yokoo S, Fujiwara T, Yoshida A, Uotani K, Morita T, Kiyono M, Hasei J, Nakata E, Kunisada T, Iwata S, Yonemoto T, Ueda K, Ozaki T. Liquid Biopsy Targeting Monocarboxylate Transporter 1 on the Surface Membrane of Tumor-Derived Extracellular Vesicles from Synovial Sarcoma. Cancers (Basel). 2021 Apr 11;13(8):1823. doi: 10.3390/cancers13081823.